More than 95% of adult infected with HBV show acute self-limited infection and eventually
eliminate the virus. In contrast, about 90% of people exposed to HBV in early childhood …

Approximately 5% of the world population is infected by the hepatitis B virus (HBV) that
causes a necroinflammatory liver disease of variable duration and severity. Chronically …

Chronic hepatitis B virus (HBV) infection is a global public health issue. There are> 250
million people chronically infected with HBV, and these chronic carriers are at high risk of …

Highlights•Hepatocellular HBV infection is noncytopathic.•HBV does not induce a
measurable innate immune response in vivo.•Robust, broad adaptive immune responses …

Approximately 5% of the world population is infected by the hepatitis B virus (HBV) which
causes a necroinflammatory liver disease of variable duration and severity. Chronically …

Chronic hepatitis B (CHB) is a widespread infectious disease with unfavorable outcomes
and life-threatening consequences for patients, in spite of modern vaccination and antiviral …

Hepatitis B virus (HBV) infection in immunocompetent adults usually results in a self-limited,
transient liver disease and viral clearance, with only a small percentage (5 to 10%) …

Host immune responses induced by hepatitis B virus (HBV) infection not only substantially
drive disease progression, but also significantly influence efficacy of antiviral treatments in …

Human hepatitis B virus (HBV) infects the liver of humans or humanoid primates. In humans,
HBV infection often causes an inflammatory liver disease–hepatitis B. The virus is …

Hepatitis B virus (HBV) infection is a non‐cytopathic hepatotropic virus that can lead to
severe liver disease including acute hepatitis, cirrhosis and hepatocellular carcinoma …